These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Bone destruction in arthritis. Gravallese EM Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632 [TBL] [Abstract][Full Text] [Related]
43. Development of proteoglycan-induced arthritis is independent of IL-17. Doodes PD; Cao Y; Hamel KM; Wang Y; Farkas B; Iwakura Y; Finnegan A J Immunol; 2008 Jul; 181(1):329-37. PubMed ID: 18566398 [TBL] [Abstract][Full Text] [Related]
44. Expression of receptor activator of nuclear factor-κB ligand is related to sex differences in collagen-induced arthritis. Ding Z; Wang Q; Pan X; Zhu Q; Lu H; Wang K; Ni X; Lu Y; Gu J Int Immunopharmacol; 2015 Oct; 28(2):892-6. PubMed ID: 25863233 [TBL] [Abstract][Full Text] [Related]
45. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Hyeon S; Lee H; Yang Y; Jeong W Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472 [TBL] [Abstract][Full Text] [Related]
46. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis. Weiss RJ; Erlandsson Harris H; Wick MC; Wretenberg P; Stark A; Palmblad K Scand J Immunol; 2005 Jul; 62(1):55-62. PubMed ID: 16092922 [TBL] [Abstract][Full Text] [Related]
48. Osteoclast-like cells in murine collagen induced arthritis. Suzuki Y; Nishikaku F; Nakatuka M; Koga Y J Rheumatol; 1998 Jun; 25(6):1154-60. PubMed ID: 9632079 [TBL] [Abstract][Full Text] [Related]
49. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation. Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755 [TBL] [Abstract][Full Text] [Related]
51. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells. Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932 [TBL] [Abstract][Full Text] [Related]
52. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411 [TBL] [Abstract][Full Text] [Related]
53. Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7. Gan K; Xu L; Feng X; Zhang Q; Wang F; Zhang M; Tan W Int Immunopharmacol; 2015 Feb; 24(2):239-246. PubMed ID: 25529994 [TBL] [Abstract][Full Text] [Related]
55. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Chu CQ; Song Z; Mayton L; Wu B; Wooley PH Ann Rheum Dis; 2003 Oct; 62(10):983-90. PubMed ID: 12972478 [TBL] [Abstract][Full Text] [Related]
56. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Kelchtermans H; Schurgers E; Geboes L; Mitera T; Van Damme J; Van Snick J; Uyttenhove C; Matthys P Arthritis Res Ther; 2009; 11(4):R122. PubMed ID: 19686583 [TBL] [Abstract][Full Text] [Related]
57. Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion. Raghu H; Cruz C; Rewerts CL; Frederick MD; Thornton S; Mullins ES; Schoenecker JG; Degen JL; Flick MJ Blood; 2015 Jan; 125(3):427-37. PubMed ID: 25336631 [TBL] [Abstract][Full Text] [Related]
58. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis. Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044 [TBL] [Abstract][Full Text] [Related]
59. STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis. Park JS; Kwok SK; Lim MA; Kim EK; Ryu JG; Kim SM; Oh HJ; Ju JH; Park SH; Kim HY; Cho ML Arthritis Rheumatol; 2014 Apr; 66(4):918-29. PubMed ID: 24757144 [TBL] [Abstract][Full Text] [Related]
60. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]